hudsonv
New
My facility will soon began a new study from Marker Therapeutic titled: Donor derived multi-tumor associated antigen specific T cells (MT-401) this will be administered to patients with AML following a hematopoietic stem cell transplantation. Can someone assist me with the coding guidelines? I'm familiar with the Autologous CAR T therapy coding guidelines but this study has me at a loss.
Thank you
Vanessa Hudson, CPC
Thank you
Vanessa Hudson, CPC